This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Oliverio joins Actineer with over 30 years of leadership experience across the nuclearmedicine, medicaldevice, and radiopharmaceutical industries, including roles at Ionetix, Imagin Molecular, and Positron.
Mayer is a 30-year-plus veteran in the healthcare information technology (HIT), EI, and the medicaldevice field. We take a collaborative approach where we review our solution offerings and hear about technologies or solutions that customers use or need. We want to share and collaborate."
Erin Griesman, Nebraska Medicine’sNuclearMedicine Operations Manager, emphasized the significance of SMS’s support, stating, “Imaging demands keep increasing and increasing, so Nebraska Medicine is trying to think outside the box. Additional information on Shared MedicalDevices is available at www.sharedmed.com.
Scholz continued, “On behalf of the entire Company, we want to express our sincere appreciation to Steve Merrick, who, in his seven years of commitment and strategic leadership, has advanced NorthStar’s innovation and radiopharmaceutical expertise to the forefront of nuclearmedicine. He holds a Ph.D.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content